Related Experiment Video
Updated: Apr 28, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Published on: October 28, 2014
Inhibiting HDAC for human hematopoietic stem cell expansion
Insights
Researchers expanded hematopoietic stem cells (HSCs) from human cord blood (CB) ex vivo. This novel epigenetic modification protocol shows potential for clinical applications in regenerative medicine.
Area of Science:
- Hematology
- Epigenetics
- Stem Cell Biology
Background:
- Hematopoietic stem cells (HSCs) are crucial for blood formation and are found in cord blood (CB).
- Ex vivo expansion of HSCs is challenging but essential for therapeutic applications.
- Epigenetics, the study of heritable gene expression changes without altering DNA sequence, is a rapidly advancing field.
Purpose of the Study:
- To develop an effective protocol for ex vivo expansion of human cord blood HSCs.
- To investigate the role of epigenetic modifications in enhancing HSC expansion.
- To assess the potential clinical applicability of the developed expansion protocol.
Main Methods:
- Utilized a combination of cytokines and specific epigenetic modifications.
- Applied the protocol to human cord blood HSCs for ex vivo expansion.
- Compared the expansion efficiency with previous methods.
Main Results:
- Achieved impressive ex vivo expansion of HSCs from human cord blood.
- Demonstrated that altering epigenetic modifications enhances HSC expansion.
- The protocol represents a significant advancement over prior techniques.
Conclusions:
- The developed protocol offers a promising strategy for expanding cord blood HSCs ex vivo.
- This method has potential for clinical consideration in regenerative medicine and transplantation.
- The study highlights the importance of epigenetics in stem cell expansion.
Abstract:
In this issue of the JCI, Chaurasia and colleagues report an impressive ex vivo expansion of HSCs from human cord blood (CB) using cytokines and altering epigenetic modifications. The application of this protocol provides information that has potential for clinical consideration. The enhanced expansion of CB HSCs is a substantial advance over recent work from the Chaurasia and Hoffman group, in which ex vivo production of human erythroid progenitor cells from CB was promoted by chromatin modification. Moreover, this study takes advantage of information from the rapidly emerging, but not yet fully elucidated, field of epigenetics.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells

